Ras-activated RSK1 phosphorylates EBP50 to regulate its nuclear localization and promote cell proliferation

HooiCheng Lim; Tzuu-Shuh Jou

doi:10.18632/oncotarget.7184

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

Ras-activated RSK1 phosphorylates EBP50 to regulate its nuclear localization and promote cell proliferation

HooiCheng Lim and Tzuu-Shuh Jou _

PDF | HTML | Supplementary Files | How to cite

Oncotarget. 2016; 7:10283-10296. https://doi.org/10.18632/oncotarget.7184

Metrics: PDF 1721 views | HTML 2025 views | ?

Abstract

HooiCheng Lim1 and Tzuu-Shuh Jou1,2

1 Graduate Institute of Molecular Medicine, National Taiwan University, Taipei, Taiwan

2 Graduate Institute of Clinical Medicine, National Taiwan University, Taipei, Taiwan

Correspondence to:

Tzuu-Shuh Jou, email:

Keywords: EBP50, nuclear localization, phosphorylation, proliferation, RSK1

Received: November 23, 2015 Accepted: January 25, 2016 Published: March 01, 2016

Abstract

Differential subcellular localization of EBP50 leads to its controversial role in cancer biology either as a tumor suppressor when it resides at the membrane periphery, or a tumor facilitator at the nucleus. However, the mechanism behind nuclear localization of EBP50 remains unclear. A RNA interference screening identified the downstream effector of the Ras-ERK cascade, RSK1, as the molecule unique for nuclear transport of EBP50. RSK1 binds to EBP50 and phosphorylates it at a conserved threonine residue at position 156 (T156) under the regulation of growth factor. Mutagenesis experiments confirmed the significance of T156 residue in nuclear localization of EBP50, cellular proliferation, and oncogenic transformation. Our study sheds light on a possible therapeutic strategy targeting at this aberrant nuclear expression of EBP50 without affecting the normal physiological function of EBP50 at other subcellular localization.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 7184

Publication Alerts

Research Papers:

Ras-activated RSK1 phosphorylates EBP50 to regulate its nuclear localization and promote cell proliferation

Abstract